Glaucoma drainage devices: state of the art
Ayyala, Ramesh S, Jessica Laursen Duarte, and . 2006. “Glaucoma Drainage Devices: State of the Art”. Expert Rev. Med. Devices 3 (4): 509-21.
Search
Search results
68 results found
Manganese and liver disease. Movement Disorders 1996;11:589.
Hauser, RA, and TA Zesiewicz. 1996. “Manganese and Liver Disease. Movement Disorders 1996;11:589.”. Movement Disorders.
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. NEJM 1995;332:1118-24.
Kordower, JH, TB Freeman, BJ Snow, FJG Vingerhoets, EJ Mufson, PR Sanberg, RA Hauser, et al. 1995. “Neuropathological Evidence of Graft Survival and Striatal Reinnervation After the Transplantation of Fetal Mesencephalic Tissue in a Patient With Parkinson’s Disease. NEJM 1995;332:1118-24.”. NEJM.
Sertraline-induced exacerbation of tics in Tourette’s syndrome. Movement Disorders 1995;10:682-684.
Hauser, RA, and TA Zesiewicz. 1995. “Sertraline-Induced Exacerbation of Tics in Tourette’s Syndrome. Movement Disorders 1995;10:682-684.”. Movement Disorders.
Bilateral fetal nigral transplantation into the post commissural putamen in Parkinson’s disease. Annals of Neurology 1995; 38:379-388.
Freeman, TB, CW Olanow, RA Hauser, GM Nauert, DA Smith, CV Borlongan, PR Sanberg, et al. 1995. “Bilateral Fetal Nigral Transplantation into the Post Commissural Putamen in Parkinson’s Disease. Annals of Neurology 1995; 38:379-388.”. Annals of Neurology.
. Parinaud’s syndrome as the initial manifestation of acquired immunodeficiency syndrome. J Neuroimaging 1994;4:113-114.
Griffin, DK, ME Shriver, and RA Hauser. 1994. “. Parinaud’s Syndrome As the Initial Manifestation of Acquired Immunodeficiency Syndrome. J Neuroimaging 1994;4:113-114.”. J Neuroimaging.
Magnetic resonance imaging of neurodegenerative disorders. J Neuroimaging 1994;4:146-158.
Hauser, RA, and CW Olanow. 1994. “Magnetic Resonance Imaging of Neurodegenerative Disorders. J Neuroimaging 1994;4:146-158.”. J Neuroimaging.
Borlongan CV, Koutzouzis TK, Freeman TB, Hauser RA, Cahill DW, Sanberg PR. Hyperactivity and hypoactivity in a rat model of Huntington’s disease: the systemic 3-nitropropionic acid model. Brain Research Protocols 1997;1:253-257.
Borlongan, CV, TK Koutzouzis, TB Freeman, RA Hauser, DW Cahill, and PR Sanberg. 1997. “Borlongan CV, Koutzouzis TK, Freeman TB, Hauser RA, Cahill DW, Sanberg PR. Hyperactivity and Hypoactivity in a Rat Model of Huntington’s Disease: The Systemic 3-Nitropropionic Acid Model. Brain Research Protocols 1997;1:253-257.”. Brain Research Protocols.
Adler CH, Sethi KD, Hauser RA, Davis TL, Hammerstad JP, Bertoni J, Taylor RL, Sanchez-Ramos J, O’Brien CF. Ropinirole for the treatment of early Parkinson’s disease. Neurology 1997;49:393-399.
Adler, CH, KD Sethi, RA Hauser, TL Davis, JP Hammerstad, J Bertoni, RL Taylor, J Sanchez-Ramos, and CF O’Brien. 1997. “Adler CH, Sethi KD, Hauser RA, Davis TL, Hammerstad JP, Bertoni J, Taylor RL, Sanchez-Ramos J, O’Brien CF. Ropinirole for the Treatment of Early Parkinson’s Disease. Neurology 1997;49:393-399.”. Neurology.
Infectious issues in human fetal neural transplantation. Cell Transplantation 1997;6:553-556.
Holt, DA, GM Nauert, AL Othberg, TS Randall, AE Willing, RH Widen, RA Hauser, PR Sanberg, CW Olanow, and TB Freeman. 1997. “Infectious Issues in Human Fetal Neural Transplantation. Cell Transplantation 1997;6:553-556.”. Cell Transplantation.